| |
| |
|
| Insider
Information: |
Brenner Randall B. |
| Relationship: |
Chief Development & Re... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Paratek Pharmaceuticals Inc |
PRTK |
Chief Development & Re... |
2023-09-21 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2023-09-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(415,209) |
0 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2023-08-09 |
4 |
AS |
$2.20 |
$60,727 |
D/D |
(27,603) |
415,209 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2023-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
67,500 |
442,812 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2022-12-21 |
4 |
AS |
$1.99 |
$9,033 |
D/D |
(4,539) |
335,312 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2022-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
339,851 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2022-12-13 |
4 |
AS |
$1.96 |
$35,627 |
D/D |
(18,177) |
324,851 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2022-12-12 |
4 |
AS |
$1.98 |
$21,988 |
D/D |
(11,105) |
343,028 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2022-10-28 |
4 |
AS |
$3.47 |
$12,201 |
D/D |
(3,516) |
354,133 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2022-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,500 |
357,649 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2022-08-09 |
4 |
AS |
$2.66 |
$52,157 |
D/D |
(19,608) |
349,149 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2022-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
47,727 |
368,757 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
67,500 |
321,030 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2021-12-15 |
4 |
AS |
$4.27 |
$67,381 |
D/D |
(15,780) |
253,530 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2021-12-14 |
4 |
AS |
$4.37 |
$33,365 |
D/D |
(7,635) |
269,310 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2021-12-13 |
4 |
AS |
$4.42 |
$19,797 |
D/D |
(4,479) |
276,945 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2021-08-17 |
4 |
AS |
$5.12 |
$44,882 |
D/D |
(8,766) |
281,424 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2021-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
21,250 |
290,190 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2021-06-04 |
4 |
AS |
$9.70 |
$96,787 |
D/D |
(9,978) |
268,940 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2021-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
28,636 |
278,918 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
121,500 |
250,282 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2020-12-14 |
4 |
AS |
$6.71 |
$58,780 |
D/D |
(8,760) |
128,782 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2020-12-11 |
4 |
AS |
$6.95 |
$42,840 |
D/D |
(6,164) |
137,542 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2020-11-13 |
4 |
AS |
$5.93 |
$49,557 |
D/D |
(8,357) |
143,706 |
0 |
% |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2020-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
21,250 |
152,063 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Development & Regulatory |
• – – |
2020-05-12 |
4 |
S |
$4.75 |
$29,441 |
D/D |
(6,198) |
130,813 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
